Enhua Pharmaceutical (002262.SZ): Oxycodone Hydrochloride Extended-Release Tablets Obtain Drug Registration Certificate
Zhitong Finance APP news, Nhwa Pharmaceutical (002262.SZ) announced that the company recently obtained the "Drug Registration Certificate" for the chemical drug oxycodone hydrochloride extended-release tablets approved and issued by the National Medical Products Administration. Oxycodone hydrochloride extended-release tablets are independently developed by the company and are an extended-release formulation that uses physical and chemical barrier technology to achieve abuse-deterrent effects for oral opioids. They are used to treat pain that is severe enough to require long-term, continuous, daily around-the-clock opioid treatment and for which alternative treatments (e.g., non-opioid drugs or immediate-release opioids) cannot adequately relieve the pain. While ensuring efficacy, they effectively improve medication safety.
Latest
3 m ago

